.jpg "Colleen R. Kelly, MD, FACG photo")
Associate Professor of Medicine
Warren Alpert Medical School of Brown University
East Providence, RI
Colleen R. Kelly, MD, FACG, is a gastroenterologist with the Lifespan Physician Group and an Associate Professor of Medicine at The Alpert Medical School of Brown University. She graduated from The Ohio State University College of Medicine in Columbus, OH, and completed internal medicine training at Boston Medical Center and Gastroenterology fellowship at the Rhode Island Hospital/Brown program. The focus of her research and clinical practice is fecal microbiota transplantation (FMT) for the treatment of C. difficile infection (CDI). Dr. Kelly was the principal investigator (PI) for a first placebo-controlled trial of FMT for treatment of recurrent CDI. She was one of the first investigators to sponsor an investigational new drug (IND) application with the FDA to conduct this trial and has served on national and international working groups focusing on regulatory issues and best practices around FMT. She is currently one of the Principal Investigators for an NIH-funded FMT national registry, investigating real-world efficacy and safety of FMT. She is actively collaborating on several studies investigating the impact of FMT on patients with Inflammatory Bowel Disease. In addition to coauthoring current FMT concensus guidelines, she is the primary author for ACG's 2021 C. difficile treatment guidelines. She is a Fellow and member of the ACG Research Committee and past member of the Women in GI Committee.
Saturday, October 22, 2022
7:50 AM – 8:00 AM ET
Saturday, October 22, 2022
1:45 PM – 3:00 PM ET
Saturday, October 22, 2022
2:05 PM – 2:25 PM ET
Saturday, October 22, 2022
2:45 PM – 3:00 PM ET
Saturday, October 22, 2022
4:55 PM – 5:15 PM ET
Sunday, October 23, 2022
7:50 AM – 8:00 AM ET
Sunday, October 23, 2022
4:55 PM – 5:15 PM ET